-002-05
储存：将未打开的瓶子储存在2°C至8°C（36°F至46°F）的冰箱中。一旦打开瓶子使用，它可以在最高30°C（86°F）的温度下储存长达31天。
请参阅随附的Omlonti完整处方信息：
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8e440b2c-fbe5-4c86-b7f3-3da00a5b2924
-----------------------------------------------
FDA Approval for OMLONTI®(Omidenepag Isopropyl Ophthalmic Solution) 0.002% for the Reduction of Elevated Intraocular Pressure in Patients with Primary Open-Angle Glaucoma or Ocular Hypertension
OMLONTI®is developed jointly by Santen and UBE. Omidenepag isopropyl, the active pharmaceutical ingredient in OMLONTI®, developed by UBE, is a relatively selective prostaglandin EP2 receptor agonist, which increases aqueous humor drainage through the conventional(or trabecular)and uveoscleral outflow pathways, and the only product with this pharmacological action. OMLONTI®was launched in Japan as Eybelis® ophthalmic solution 0.002% in November 2018, and was filed for marketing approval in Asian countries in stages.
PRINCIPAL DISPLAY PANEL - 2.5ML BOTTLE CARTON
NDC 65086-002-05
Santen
OMLONTI(omidenepag isopropyl ophthalmic solution) 0.002%
FOR TOPICAL USE
IN THE EYES
STERILE
RX ONLY
2.5mL |
